Your browser doesn't support javascript.
loading
Alterations in the RB Pathway With Inactivation of RB1 Characterize Glioblastomas With a Primitive Neuronal Component.
Chkheidze, Rati; Raisanen, Jack; Gagan, Jeffrey; Richardson, Timothy E; Pinho, Marco C; Raj, Karuna; Achilleos, Michael; Slepicka, Chenelle; White, Charles L; Evers, Bret M; Patel, Toral R; Malter, James S; Hatanpaa, Kimmo J.
Afiliação
  • Chkheidze R; From the Department of Pathology, University of Alabama at Birmingham, Birmingham, Alabama, USA.
  • Raisanen J; Department of Pathology, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
  • Gagan J; Department of Pathology, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
  • Richardson TE; Department of Pathology, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
  • Pinho MC; Department of Pathology, State University of New York, Upstate Medical University, Syracuse, New York, USA.
  • Raj K; UT Health San Antonio, San Antonio, Texas, USA.
  • Achilleos M; Department of Radiology, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
  • Slepicka C; Department of Radiology, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
  • White CL; Department of Radiology, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
  • Evers BM; Department of Radiology, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
  • Patel TR; Department of Pathology, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
  • Malter JS; Department of Pathology, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
  • Hatanpaa KJ; Department of Neurosurgery, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
J Neuropathol Exp Neurol ; 80(12): 1092-1098, 2021 12 29.
Article em En | MEDLINE | ID: mdl-34850045
A primitive neuronal component is a feature of some glioblastomas but defining molecular alterations of this histologic variant remains uncertain. We performed next-generation sequencing of 1500 tumor related genes on tissue from 9 patients with glioblastoma with a primitive component (G/PN) and analyzed 27 similar cases from the Cancer Genome Atlas (TCGA) dataset. Alterations in the RB pathway were identified in all of our patients' tumors and 81% of TCGA tumors with the retinoblastoma tumor suppressor gene (RB1) commonly affected. Although RB1 mutations were observed in some conventional glioblastomas, the allelic fractions of these mutations were significantly higher in tumors with a primitive neuronal component in both our and TCGA cohorts (median, 72% vs 25%, p < 0.001 and 80% vs 40%, p < 0.02, respectively). Further, in 78% of patients in our cohort, RB expression was lost by immunohistochemistry. Our findings indicate that alterations in the RB pathway are common in G/PNs and suggest that inactivation of RB1 may be a driving mechanism for the phenotype.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Glioblastoma / Ubiquitina-Proteína Ligases / Proteínas de Ligação a Retinoblastoma Tipo de estudo: Prognostic_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Neuropathol Exp Neurol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Glioblastoma / Ubiquitina-Proteína Ligases / Proteínas de Ligação a Retinoblastoma Tipo de estudo: Prognostic_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Neuropathol Exp Neurol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos